UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054428
Receipt number R000062166
Scientific Title Observational study to verify the effectiveness of the medical device Relive Shirt
Date of disclosure of the study information 2024/06/01
Last modified on 2024/11/17 09:35:20

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Observational study to verify the effectiveness of the medical device Relive Shirt

Acronym

Verification of Relive shirt

Scientific Title

Observational study to verify the effectiveness of the medical device Relive Shirt

Scientific Title:Acronym

Verification of Relive shirt

Region

Japan


Condition

Condition

Healthy volunteer

Classification by specialty

Nursing

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We will verify the safety of the Relive Shirt and clarify its effects on the living body and changes in physical functions, including its effects on sleep quality and circulatory and respiratory functions.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Allergy incidence after 30 days

Key secondary outcomes

Total sleep time


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification

NO

Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Wearing Relive shirt

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Those who wear the Relive shirt and consent to sleep evaluation by Fitbit tracker
2) Items that do not interfere with daily activities

Key exclusion criteria

1) Those taking oral medication for sleep or mental illness due to health reasons
2) Those with skin allergies

Target sample size

10


Research contact person

Name of lead principal investigator

1st name TORU
Middle name
Last name MIZUGUCHI

Organization

Sapporo Medical University

Division name

Department of Nursing

Zip code

0608556

Address

S1, W17, Chuo-Ku, Sapporo

TEL

0116112111

Email

tmizu@sapmed.ac.jp


Public contact

Name of contact person

1st name TORU
Middle name
Last name MIZUGUCHI

Organization

Sapporo Medical University

Division name

Department of Nursing

Zip code

0608556

Address

S1, W17, Chuo-ku, Sapporo

TEL

0116112111

Homepage URL


Email

tmizu@sapmed.ac.jp


Sponsor or person

Institute

Sapporo Medical Univesity

Institute

Department

Personal name



Funding Source

Organization

Sapporo Medical University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sapporo Medical University Ethics Committee

Address

s1, W17, Chuo-ku, Sapporo

Tel

0116112111

Email

rskk@sapmed.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 06 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2024 Year 05 Month 18 Day

Date of IRB

2024 Year 05 Month 31 Day

Anticipated trial start date

2024 Year 06 Month 01 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The ethics committee determined that it was not acceptable for a public research institution to publish health evaluations using products that were registered as medical devices.


Management information

Registered date

2024 Year 05 Month 18 Day

Last modified on

2024 Year 11 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000062166